Keywords: Muscle, Rare disease, metabolism, molecular imaging
Motivation: Pompe disease is a glycogen storage disease featuring abnormal glycogen accumulation in tissues. Noninvasive methods for assessing disease progression and treatment effect are highly needed.
Goal(s): To use glycoNOE MRI to assess muscle glycogen levels in Pompe disease and the effect of treatment on these levels.
Approach: GlycoNOE MRI and a lineshape fitting model were used to detect glycogen levels in skeletal muscle in a mouse model of Pompe disease. Various therapies were assessed.
Results: GlycoNOE MRI glycogen quantification can discriminate between controls, mice with Pompe disease, and different treatment effects.
Impact: Monitoring of glycogen levels is essential for assessing Pompe disease load and treatment efficacy. GlycoNOE MRI offers the possibility to non-invasively map glycogen levels in tissue using standard MRI scanners.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords